PRESS RELEASE published on 05/23/2025 at 09:00, 11 months 16 days ago Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026 Alzchem Group AG successfully completes long-term succession planning as Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer from January 1, 2026 Chief Operating Officer Supervisory Board Succession Planning Alzchem Group AG Dr. Jürgen Sans
BRIEF published on 05/09/2025 at 14:25, 11 months 29 days ago Alzchem Group AG Increases Dividend by 50% and Re-elects Supervisory Board Annual General Meeting Shareholder Value Supervisory Board Fiscal Year 2024 Dividend Increase
BRIEF published on 05/09/2025 at 14:25, 11 months 29 days ago Alzchem Group AG augmente son dividende de 50 % et réélit son conseil de surveillance Exercice 2024 Conseil De Surveillance Valeur Actionnariale Assemblée Générale Annuelle Augmentation Des Dividendes
PRESS RELEASE published on 05/09/2025 at 14:20, 11 months 29 days ago Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members Alzchem Group AG approves 50% dividend increase to EUR 1.80 at Annual General Meeting and re-elects Supervisory Board members. Successful fiscal year 2024 showcased Annual General Meeting Supervisory Board Fiscal Year 2024 Dividend Increase Alzchem Group AG
BRIEF published on 04/30/2025 at 07:05, 1 year ago Alzchem Group AG annonce une croissance continue de ses bénéfices au premier trimestre 2025 Croissance De L'EBITDA Groupe Alzchem AG Produits Chimiques De Spécialité Résultats Du Premier Trimestre 2025 Expansion De La Nitroguanidine
BRIEF published on 04/30/2025 at 07:05, 1 year ago Alzchem Group AG Reports Continued Earnings Growth in Q1 2025 Alzchem Group AG EBITDA Growth Specialty Chemicals Q1 2025 Earnings Nitroguanidine Expansion
PRESS RELEASE published on 04/30/2025 at 07:00, 1 year ago Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched Alzchem Group AG achieves earnings growth in Q1 2025 despite lower revenue, plans to expand nitroguanidine capacity. Positive outlook for sales and EBITDA growth in 2025 Earnings Growth Sales Forecast Alzchem Group AG Q1 2025 Nitroguanidine Expansion
BRIEF published on 03/21/2025 at 13:57, 1 year 1 month ago Alzchem Group AG organise avec succès la conférence sur la créatine 2025 Compléments Alimentaires Recherche Scientifique Événement Hybride Groupe Alzchem AG Conférence Sur La Créatine 2025
BRIEF published on 03/21/2025 at 13:57, 1 year 1 month ago Alzchem Group AG Hosts Successful Creatine Conference 2025 Scientific Research Nutritional Supplements Alzchem Group AG Hybrid Event Creatine Conference 2025
PRESS RELEASE published on 03/21/2025 at 13:52, 1 year 1 month ago Alzchem Group AG: Successful Creatine Conference 2025 inspires international experts Alzchem Group AG organized a successful Creatine Conference 2025 in Munich, bringing together international experts to share latest research findings and innovations in creatine supplementation Innovation Research Alzchem Group AG Supplementation Creatine Conference 2025
Published on 05/08/2026 at 10:30, 1 hour 57 minutes ago Previewing the Product Logic Behind Waton’s Next AI Trading Platform
Published on 05/08/2026 at 01:50, 10 hours 37 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 11 hours 42 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 12 hours 27 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 12 hours 57 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/08/2026 at 12:01, 25 minutes ago Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 05/08/2026 at 11:58, 28 minutes ago EQS-Adhoc: Aurubis AG: Aurubis AG raises 2025/26 full-year forecast based on improved market outlook
Published on 05/08/2026 at 11:45, 42 minutes ago MINISFORUM and Intel to Unveil a New Chapter of Agent NAS
Published on 05/08/2026 at 11:30, 57 minutes ago Mutares launches voluntary public tender offer for outstanding Nordic Bond 2023/2027
Published on 05/07/2026 at 19:15, 17 hours 12 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 17 hours 12 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 17 hours 21 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 17 hours 21 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 17 hours 27 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL